Inhibition of Cdk5 induces cell death of tumor-initiating cells

BACKGROUND: Tumour-initiating cells (TICs) account for chemoresistance, tumour recurrence and metastasis, and therefore represent a major problem in tumour therapy. However, strategies to address TICs are limited. Recent studies indicate Cdk5 as a promising target for anti-cancer therapy and Cdk5 ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandl, Melanie M, Zhang, Siwei, Ulrich, Melanie, Schmoeckel, Elisa, Mayr, Doris, Vollmar, Angelika M, Liebl, Johanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379151/
https://www.ncbi.nlm.nih.gov/pubmed/28222068
http://dx.doi.org/10.1038/bjc.2017.39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379151/
https://www.ncbi.nlm.nih.gov/pubmed/28222068
http://dx.doi.org/10.1038/bjc.2017.39

Ejemplares similares